Cytovation

Cytovation AS

This company develops peptide-based immunotherapy treatments for patients with solid tumours and cancers driven by the Wnt/β-catenin signalling pathway.

Pep-Therapy

This biotechnology company develops intracellular peptide-based targeted therapies to treat patients with advanced solid tumours, including pancreatic and ovarian cancers.

TwoStep Therapeutics

The company develops peptide-drug conjugates and targeted therapies for patients with solid tumours.

Cytospire Therapeutics

This company develops multispecific immune cell engager antibodies for cancer patients to enhance and direct immune system activity against solid tumours.

Nykode Therapeutics

This company develops immunotherapy vaccines to treat patients with cancer and autoimmune diseases.

Sift Bio

The company develops a peptide immunotherapy platform that uses artificial intelligence to identify microbial analogs for treating solid tumours in cancer patients.

Cybrexa

The company develops peptide-drug conjugate therapeutics for oncology patients to deliver anti-cancer agents directly into tumours using a pH-sensitive targeting platform.

Waypoint Bio

This company develops cell therapies for solid tumours using a spatial biology and machine learning platform to assist patients with difficult-to-treat cancers.